概念板块个股详情
基因编辑 添加自选

基因编辑是一种新兴的比较精确的能对生物体基因组特定目标基因进行修饰的一种基因工程技术或过程,在基因研究、基因治疗和遗传改良等方面展示出了巨大的潜力。 该概念板块包含了业务涉及基因编辑的主要美股上市公司。

  • 1452.984
  • -5.552-0.38%
交易中 05/23 10:50 (美东)
1460.061最高价1449.106最低价
成分股: 10只领涨股: SGMO+4.87%
分时
  • 5日
  • 日K
  • 周K
  • 月K
  • 季K
  • 年K
成分股
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
SGMOSangamo Therapeutics
0.6680.032+5.02%78.49万50.70万0.6500.6360.6700.6021.39亿1.14亿2.08亿1.71亿+9.73%+27.61%+32.78%-37.58%+55.33%-49.78%+22.93%--0.46%亏损亏损10.64%生物技术
VRTX福泰制药
449.2601.730+0.39%25.06万1.13亿449.580447.530450.540446.6701159.33亿1155.80亿2.58亿2.57亿+1.96%+7.22%+12.96%+5.22%+26.62%+35.06%+10.41%--0.10%29.1532.340.87%生物技术
A安捷伦科技
151.290-1.580-1.03%21.32万3234.07万152.470152.870152.470150.840443.36亿441.64亿2.93亿2.92亿-1.81%+5.95%+10.04%+14.32%+18.97%+25.96%+9.00%0.60%0.07%36.1936.111.07%诊断与研究
CRBUCaribou Biosciences
3.065-0.045-1.45%61.94万188.63万3.1103.1103.1203.0002.77亿2.12亿9031.78万6903.00万-14.62%-16.03%-18.48%-61.88%-47.79%-29.46%-46.51%--0.90%亏损亏损3.86%生物技术
BLUEbluebird bio
0.954-0.029-2.97%153.75万146.93万0.9870.9840.9900.9301.84亿1.83亿1.93亿1.92亿-10.81%-2.08%+3.41%-45.47%-75.28%-73.56%-30.84%--0.80%亏损亏损6.10%生物技术
CRSPCRISPR Therapeutics
55.050-1.750-3.08%51.54万2843.56万56.80056.80056.80054.32046.75亿45.90亿8491.81万8338.31万-1.11%+2.80%+2.46%-37.21%-17.50%-13.78%-12.06%--0.62%亏损亏损4.37%生物技术
NTLAIntellia Therapeutics
24.995-0.975-3.75%38.76万973.76万25.94025.97025.97024.76024.11亿23.83亿9647.54万9533.04万-4.67%+8.67%+18.07%-19.42%-19.19%-40.15%-18.02%--0.41%亏损亏损4.66%生物技术
BEAMBeam Therapeutics
23.940-0.940-3.78%22.51万537.91万24.91024.88024.91023.57019.71亿18.31亿8231.11万7649.14万+0.63%+6.21%+10.83%-45.10%-14.74%-25.68%-12.05%--0.29%亏损亏损5.39%生物技术
EDITEditas Medicine
5.773-0.248-4.11%54.65万315.84万6.0106.0206.0515.6554.75亿4.41亿8223.80万7644.68万-3.79%+14.65%+7.90%-34.85%-45.59%-38.92%-43.02%--0.72%亏损亏损6.58%生物技术
APLSApellis Pharmaceuticals
40.720-2.880-6.61%28.34万1174.76万43.02043.60043.12740.59049.42亿33.28亿1.21亿8172.44万-3.05%-4.23%-15.04%-36.42%-24.41%-52.18%-31.97%--0.35%亏损亏损5.82%生物技术